At what enterprise value was ACTEON acquired in 2006?

During the acquisition of ACTEON by EDMOND DE ROTHSCHILD CAPITAL PARTNERS in 2006, the transaction's Enterprise Value is estimated to be in the range of 100M - 350M EUR.

What was the EV/EBITDA of ACTEON when it was acquired by EDMOND DE ROTHSCHILD CAPITAL PARTNERS?

The estimated EV/EBITDA multiple for ACTEON is in the range of 5x - 12x.

What was the revenue of ACTEON at the time of the deal?

The revenue of ACTEON at the time of the deal is estimated to be in the range of 50M - 100M EUR.

What was the EBITDA of ACTEON during the acquisition?

ACTEON's EBITDA is estimated to be in the range of 5M - 25M EUR.

How is the data for the ACTEON acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the ACTEON deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://capitalfinance.lesechos.fr/deals/lbo/acteon-soigne-son-actionnariat-122964

← DATABASE

Home Database Healthcare & PharmaACTEON

01/2006

ACTEON acquired by EDMOND DE ROTHSCHILD CAPITAL PARTNERS

FRANCE Life Sciences / Medical Devices EV 100M - 350M EUR

Context

Acteon (formerly Satelec-Pierre Rolland), a Mérignac-based medical-dental equipment and consumables manufacturer, has finalized a LBO transaction. Led by Edmond de Rothschild Capital Partners (ERCP) through the special purpose vehicle Financière Noé, the private equity sponsor acquires a 51% controlling interest, while the management team rolls over its equity to retain a 49% stake. Historical shareholders IDI, Edmond de Rothschild Investment Partners (ERIP), and mezzanine provider ICG are converting their stakes into the new structure, facilitating the complete exits of ABN Amro and XAnge Capital. The leveraged financing package comprises a senior debt facility structured across seven tranches and a mezzanine layer. Backed by its strong market positioning, the enterprise is well-placed to leverage its reconstituted investor base to accelerate its high-tech product pipeline and expand its global market presence.

ACTEON, which reported an EBITDA margin of in 2005, is valued in this transaction at an EV/EBITDA multiple of , a level as low as the average currently observed in the Healthcare & Pharma sector (15.9x).

-> Deep-dive in Healthcare & Pharma market trends

Target

Acteon is a France company specialized in Dental Technology. The organization has built its name as a high-fidelity provider of specialized medical devices, particularly leading the field in ultrasound surgery and digital medical imaging. Instead of producing generic dental tools, they thrive on a philosophy of clinical precision, offering innovative hardware that enables dentists and surgeons to perform minimally invasive procedures with superior imaging clarity. Their growth is currently fueled by a rigorous focus on new product development, a shift that has allowed them to break out of historical stagnation and capture significant market share in fast-growing dental tech segments.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2005

2004

Other operations with ACTEON

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
Date	Acquirer	Target	Country	Sector
08/2018	DENTRESSANGLE	ACTEON	FRANCE	Medical Devices
06/2016	BRIDGEPOINT / RAISE / FLEXSTONE PARTNERS	ACTEON	FRANCE	Medical Devices

REFERENCES

Valuation range: EV 100M - 350M EUR

Revenue range: 50M - 100M EUR

EBITDA range: 5M - 25M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of ACTEON by EDMOND DE ROTHSCHILD CAPITAL PARTNERS are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Acquirer: edmond de rothschild capital partners